Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C in Septic Shock
NCT06224881Phase 4Completed
- Sponsor
- Cairo University
- Start
- Dec 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ascorbic acid in septic shock (2 arms), sponsored by Cairo University. Primary endpoints: C-reactive protein at 4 days and Mean arterial blood pressure at 4 days. Started Dec 2021; status: completed.
02
Drugs
ascorbic acid
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06224881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06224881.